9 studies found for:    ogx-427
Show Display Options
Rank Status Study
1 Active, not recruiting A Phase 2 Study Comparing Chemotherapy in Combination With OGX-427 or Placebo in Patients With Bladder Cancer
Conditions: Urologic Neoplasms;   Metastatic Bladder Cancer;   Urinary Tract Neoplasms
Interventions: Drug: OGX-427 600 mg;   Drug: OGX-427 1000 mg;   Drug: Placebo
2 Active, not recruiting OGX-427 in Castration Resistant Prostate Cancer Patients
Condition: Castration Resistant Prostate Cancer
Interventions: Drug: OGX-427 and Prednisone;   Drug: Prednisone
3 Recruiting Phase II Trial of Carboplatin and Pemetrexed +/- OGX-427 in Untreated Stage IV Non-Squamous-Non-Small-Cell Lung Cancer
Condition: Non Squamous Non Small Cell Lung Cancer
Interventions: Drug: OGX-427;   Drug: Placebo
4 Recruiting Phase II Trial Of Gemcitabine Plus Nab-Paclitaxel +/- OGX-427 In Patients With Metastatic Pancreatic Cancer
Condition: Pancreatic Cancer
Interventions: Drug: OGX-427;   Drug: Placebo
5 Completed Safety Study of an Antisense Product in Prostate, Ovarian, NSCL, Breast or Bladder Cancer
Condition: Neoplasms
Interventions: Drug: OGX-427;   Drug: Docetaxel
6 Unknown  A Study for Treatment of Superficial Bladder Cancer Using OGX-427
Condition: Bladder Cancer
Intervention: Drug: OGX-427
7 Recruiting Phase 2 Study of Docetaxel +/- OGX-427 in Patients With Relapsed or Refractory Metastatic Bladder Cancer
Conditions: Bladder Cancer;   Urothelial Carcinoma
Interventions: Drug: OGX-427;   Drug: Docetaxel
8 Recruiting OGX-427 in Metastatic Castrate-Resistant Prostate Cancer With Prostate-Specific Antigen Progression While Receiving Abiraterone
Conditions: Prostate Cancer;   Metastatic Castrate-Resistant Prostate Cancer;   PSA
Interventions: Drug: OGX-427;   Drug: Abiraterone Acetate;   Drug: Prednisone
9 Recruiting Analysis of the Mechanisms of Actions of Heat Shock Protein (Hsp27) Responsible of the Androgen-independent Evolution in Prostate Cancer
Condition: Androgen-independent Prostate Cancer
Intervention: Procedure: Realisation of blood sample, urinary sample and tumor biopsy

Indicates status has not been verified in more than two years